Letter to the Editor: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?

被引：6
|
作者：
Giovanella, Luca [1 ,2 ]
Cosma, Chiara [3 ]
Plebani, Mario [3 ]
机构：
[1] Oncol Inst Southern Switzerland, Dept Nucl Med, CH-6500 Bellinzona, Switzerland
[2] Oncol Inst Southern Switzerland, Thyroid Ctr, CH-6500 Bellinzona, Switzerland
[3] Univ Hosp Padua, Dept Lab Med, I-35128 Padua, Italy
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2017年 / 102卷 / 06期
关键词：
RISK;
D O I：
10.1210/jc.2016-3983
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2113 / 2114
页数：2
相关论文
共 50 条
  • [31] Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy
    Park, Suyeon
    Kim, Won Gu
    Song, Eyun
    Oh, Hye-Seon
    Kim, Mijin
    Kwon, Hyemi
    Jeon, Min Ji
    Kim, Tae Yong
    Shong, Young Kee
    Kim, Won Bae
    THYROID, 2017, 27 (04) : 524 - 530
  • [32] Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
    Klain, Michele
    Pace, Leonardo
    Zampella, Emilia
    Mannarino, Teresa
    Limone, Simona
    Mazziotti, Emanuela
    De Simini, Giovanni
    Cuocolo, Alberto
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [33] RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
    Ruan, Maomei
    Shen, Yan
    Chen, Libo
    Li, Minghua
    ONCOLOGY LETTERS, 2013, 6 (02) : 480 - 486
  • [34] Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma
    Spencer, CA
    Takeuchi, M
    Kazarosyan, M
    Wang, CC
    Guttler, RB
    Singer, PA
    Fatemi, S
    LoPresti, JS
    Nicoloff, JT
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1121 - 1127
  • [35] Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin
    Bart de Keizer
    Hans P. F. Koppeschaar
    Pierre M. J. Zelissen
    Cees J. M. Lips
    Peter P. van Rijk
    Aalt van Dijk
    John M. H. de Klerk
    European Journal of Nuclear Medicine, 2001, 28 : 198 - 202
  • [36] Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin
    de Keizer, B
    Koppeschaar, HPF
    Zelissen, PMJ
    Lips, GJM
    van Rijk, PP
    van Dijk, A
    de Kerk, JMH
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (02) : 198 - 202
  • [37] Urinary iodine concentration and radioactive iodine therapeutic response in patients with differentiated thyroid cancer
    Jiang, Yuyan
    Jin, Jiahui
    Fan, Jingzheng
    Huang, Chao
    Jia, Qiang
    Tan, Jian
    He, Xianghui
    Zheng, Xiangqian
    Zhao, Yue
    Zhang, Qing
    Meng, Zhaowei
    Wang, Yan
    BIOMARKERS IN MEDICINE, 2021, 15 (11) : 879 - 890
  • [38] Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine
    Sonmez, Bircan
    Bektas, Ozlen
    Erkut, Nergiz
    Sonmez, Mehmet
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (04) : 306 - 313
  • [39] Research on related factors of salivary gland injury in patients with differentiated thyroid cancer treated with radioactive iodine
    Li, Xiaoqian
    Tong, Huiming
    Luo, Liping
    Huang, Nan
    Yue, Rongli
    Ju, Fang
    Qin Zhuoqi
    Yang, Suyun
    Wang Hongliang
    Cheng, Yan
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [40] Value of serum thyroglobulin measurement in patients operated on for well differentiated thyroid carcinoma
    Rüter, A
    Smeds, S
    Lennquist, S
    EUROPEAN JOURNAL OF SURGERY, 1998, 164 (09) : 665 - 671
12345